Drug delivery approaches for anti-HIV drugs

This publication has 104 references indexed in Scilit:

• 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes
  Biochemical and Biophysical Research Communications, 1991
• Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: Anti-HIV activity, physical properties, and interaction with plasma proteins
  Biochemical and Biophysical Research Communications, 1990
• Biology of retroviruses: Detection, molecular biology, and treatment of retroviral infection
  Journal of the American Academy of Dermatology, 1990
• Enhanced transdermal derivery of zidovudine in rats and human skin.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
• Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity
  Biochemical and Biophysical Research Communications, 1989
• Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
  New England Journal of Medicine, 1989
• Antiviral Therapy in Human Immunodeficiency Virus Infection
  Drugs, 1989
• Drug Delivery Systems. 1. Site‐Specific Drug Delivery Using Liposomes as Carriers
  The Journal of Clinical Pharmacology, 1989
• Effect of several penetration enhancers on the percutaneous absorption of indomethacin in hairless rats.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
• Enhancement of percutaneous absorption of molsidomine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1987